Activity of Matrix Metalloproteinase-2 (MMP-2) in Canine Oronasal Tumors
Overview
Affiliations
Activity of matrix metalloprotease-2 (MMP-2) and the expression of its related molecules were examined in spontaneous canine oronasal tumors. Tissue samples from melanoma and squamous cell carcinoma possessed higher MMP-2 activity, as shown in gelatin zymography, in comparison with acanthomatous epulis and nasal adenocarcinoma. Regional lymph node invasion and distant metastases were more frequently observed in the MMP-2 positive cases. There were no significant differences by RT-PCR examination in the expression of the genes encoding MMP-2, MT1-MMP and TIMP-2 among the tumor histological types. However, the MMP-2/TIMP-2 ratio showed a significantly higher level of the genes in the malignant oral melanoma and squamous cell carcinoma. The MMP-2/TIMP-2 ratio was also positively correlated with MMP-2 activity in gelatin zymography. These results indicate that the MMP-2/TIMP-2 ratio may be of value in evaluating the prognosis in canine oronasal cavity tumors.
Massimini M, Romanucci M, De Maria R, Della Salda L Front Vet Sci. 2021; 8:722432.
PMID: 34631854 PMC: 8494780. DOI: 10.3389/fvets.2021.722432.
Inhibitory Effects of a Reengineered Anthrax Toxin on Canine Oral Mucosal Melanomas.
Nishiya A, Nagamine M, da Fonseca I, Miraldo A, Scattone N, Luiz Guerra J Toxins (Basel). 2020; 12(3).
PMID: 32121654 PMC: 7150776. DOI: 10.3390/toxins12030157.
Divya M, Maiti S, Sangeetha P, Shivaraju S, Kumar N, Tiwari A J Stem Cells Regen Med. 2020; 15(2):24-34.
PMID: 31983855 PMC: 6971383.
Hosseini E, Pedram B, Bahrami A, Touni S, Malayeri H, Mokarizadeh A Tumour Biol. 2014; 36(2):929-37.
PMID: 25315185 DOI: 10.1007/s13277-014-2666-6.
Matrix metalloproteinases and their inhibitors in canine mammary tumors.
Aresu L, Giantin M, Morello E, Vascellari M, Castagnaro M, Lopparelli R BMC Vet Res. 2011; 7:33.
PMID: 21726449 PMC: 3141405. DOI: 10.1186/1746-6148-7-33.